Infliximab treatment in refractory Kawasaki syndrome.
Indian J Pediatr
; 75(5): 521-2, 2008 May.
Article
em En
| MEDLINE
| ID: mdl-18537019
ABSTRACT
Kawasaki syndrome is one of the commonest vasculitides in pediatric age group with devastating consequences if not treated early. Intravenous Gammaglobulin leads to rapid amelioration of clinical symptoms and significantly decreases the risk of development of coronary artery aneurysms. Occasionally, Kawasaki disease may be resistant to I/V IgG. We present our experience with one such patient who ultimately respondend to infliximab therapy.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Anti-Inflamatórios
/
Anticorpos Monoclonais
/
Síndrome de Linfonodos Mucocutâneos
Idioma:
En
Ano de publicação:
2008
Tipo de documento:
Article